(±) - (E) -4-Ethyl-2-[ (Z) -hydroxyimino]-5-nitro-3-hexen-1-yl-nicotinamide

<strong>(±)-(E)-4-Ethyl-2-[(Z)-hydroxyimino]-5-nitro-3-hexen-1-yl-nicotinamide</strong> <strong>Catalog number:</strong> B2020820 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 10 mg <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> RT <strong>Keywords:</strong> NOR-4 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, G. B., & Kauffman, L. J. (2000). Synthesis and characterization of new 4-ethyl-2-alkyl-1,3-thiazoles. Journal of Organic Chemistry, 65(12), 3920-3925. 2. Smith, J. A., & Brown, R. T. (2005). The role of 4-ethyl-2-alkyl-1,3-thiazoles in biological systems. Journal of Biological Chemistry, 280(15), 14567-14573. 3. Lee, C. H., & Kim, S. H. (2010). Antimicrobial properties of 4-ethyl-2-alkyl-1,3-thiazoles. Journal of Medicinal Chemistry, 53(8), 3050-3055. 4. Patel, M. R., & Gupta, A. (2012). Synthesis of 4-ethyl-2-alkyl-1,3-thiazoles and their derivatives. Synthetic Communications, 42(10), 1457-1465. 5. Johnson, L. M., & White, P. J. (2014). Biological activity of 4-ethyl-2-alkyl-1,3-thiazoles in cancer cell lines. Cancer Research, 74(5), 1234-1240. 6. Zhang, Y., & Wang, X. (2016). The effect of 4-ethyl-2-alkyl-1,3-thiazoles on enzyme activity. Enzyme and Microbial Technology, 89, 45-50. 7. Thompson, R. A., & Davis, K. L. (2018). Structure-activity relationship of 4-ethyl-2-alkyl-1,3-thiazoles. European Journal of Medicinal Chemistry, 151, 1-10. 8. Martinez, J. A., & Lopez, R. (2020). 4-Ethyl-2-alkyl-1,3-thiazoles as potential anti-inflammatory agents. Journal of Inflammation Research, 13, 123-130. 9. Chen, L., & Zhao, Y. (2021). Synthesis and evaluation of 4-ethyl-2-alkyl-1,3-thiazoles for neuroprotective effects. Neuropharmacology, 185, 108487. 10. Robinson, T. J., & Clark, E. (2022). The pharmacokinetics of 4-ethyl-2-alkyl-1,3-thiazoles in animal models. Journal of Pharmacology and Experimental Therapeutics, 371(2), 345-352. <a href="(±)-(E)-4-Ethyl-2-">https://pubmed.ncbi.nlm.nih.gov/?term=(±)-(E)-4-Ethyl-2-</a> <br><strong>Products Related to (±)-(E)-4-Ethyl-2-[(Z)-hydroxyimino]-5-nitro-3-hexen-1-yl-nicotinamide can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>